1.
Bonadio RR da CC, Testa L, Tavares M, Assad-Suzuki DA, Rosa DD, Gagliato D de M, et al. Treatment patterns and safety of adjuvant therapy after chemoimmunotherapy for early-stage triplenegative breast cancer in a real-world scenario: the Neo-Real/GBECAM-0123 study. MAST [Internet]. 2026 Feb. 24 [cited 2026 May 20];35(suppl.1). Available from: https://mastology.org/journal/article/view/1146